04Mar
Global Private Equity Newsletter - Winter 2020 Edition: Deals in the Life Sciences Sector Article 1: Value Drivers and Risks
As the private equity industry matures, and the deal landscape becomes more competitive, private equity sponsors are becoming more prepared and capable of investing in sectors previously considered overly-regulated, requiring advanced chemistry or...
By:
Dechert LLP
Related
On April 17, 2020, India announced a change to its foreign investment policy under which investments...
Read More >
Design-build contracts (and their lesser utilized counterpart—engineering, procurement, and constru...
Read More >
More and more, I have noticed employees are recording their employers. Smartphones, along with other...
Read More >
In This Issue. The U.S. House of Representatives voted to approve the SAFE Banking Act, which would ...
Read More >
As noted in our recent post, absent extraordinary legislative action or prompt legal challenge, by A...
Read More >
On July 23, 2019, the Michigan Court of Appeals affirmed dismissal of an age-discrimination complain...
Read More >